BioStack Raises $9.5 Million to Build Medical AI Training Datasets from Patient Records

BioStack Secures Major Funding for Medical AI Infrastructure

YC-backed healthtech startup BioStack has raised $9.5 million in seed funding from Peak XV, DCVC, and Afore Capital, positioning itself at the forefront of medical AI data infrastructure1

1

2

2

. The funding round also saw participation from Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, and Y Combinator, reflecting strong investor confidence in the startup's mission to build data infrastructure for next-generation medical AI2

2

.

Founded in 2025 by Sanat Mishra and Parth Patwa, BioStack addresses a critical challenge in healthcare: fragmented clinical information scattered across disparate systems. The healthtech startup operates across India, the US, Brazil, and Argentina, with access to more than 100 million de-identified patient records1

1

. BioStack raises $9.5 million specifically to expand hospital partnerships and scale its technology stack for AI model training applications.

Building Comprehensive Patient Datasets from Fragmented Sources

BioStack's core innovation lies in aggregating fragmented clinical data from multiple sources including electronic health records (EHRs), medical imaging, clinical notes, medications, medical scans, pathology reports, prescriptions, and treatment histories1

1

2

2

. The startup transforms this scattered information into complete patient records that serve as proprietary datasets for research, biotechnology, and the development of medical AI models.

The scale of data aggregation is substantial. BioStack has processed 100 million de-identified patient records, several hundred thousand fragmented X-rays, MRIs and CT scans, and several million telehealth audio transcripts2

2

. These comprehensive patient datasets enable AI developers to train models on real-world clinical scenarios while maintaining patient privacy through custom workflows and de-identification protocols.

Expanding Hospital Partnerships and Market Presence

The fresh capital from this seed funding will fuel BioStack's expansion across international markets. The startup currently collaborates with multiple hospitals across the US, Brazil, and Argentina, establishing a global footprint for medical AI data infrastructure2

2

. In India, BioStack is connecting cancer patients with an investigational cancer vaccine program, demonstrating practical applications beyond pure data aggregation2

2

.

According to CEO Sanat Mishra, "We're building the infrastructure that connects all of the clinical information and makes it useful, both for clinicians making decisions today and for the researchers and AI developers building the future of medicine"2

2

. A significant portion of the funding round proceeds will support scaling the tech stack and ramping up hiring across engineering and research teams to accelerate this vision.

Medical AI Applications and Use Cases

BioStack's platform enables multiple critical use cases for medical AI development. The startup offers AI model evaluation, disease modeling, biomarker discovery, patient stratification, and treatment-response analysis2

2

. These capabilities address fundamental needs in pharmaceutical research, clinical decision support, and precision medicine development.

The comprehensive patient datasets created by BioStack allow AI developers to train models that understand complete patient journeys rather than isolated data points. This holistic approach to AI model training could accelerate breakthroughs in diagnostic accuracy, treatment optimization, and drug discovery by providing the rich, contextual information that medical AI systems require.

India's Growing Role in AI Dataset Generation

BioStack's fundraise reflects a broader trend positioning India as a training ground for collecting datasets that power AI models. The Indian AI training dataset market is projected to reach $1.3 billion by 2033, driven by the country's large population and growing digital health infrastructure2

2

. Startups like Awign, Objectways, and Human Archive are building pipelines to supply data to AI developers, while Provision Labs recently launched to collect data for physical AI systems2

2

.

Watch for how BioStack navigates regulatory frameworks across multiple countries as it scales. The startup's ability to maintain patient privacy while delivering valuable datasets will determine its success in an increasingly scrutinized healthcare AI landscape. As medical AI models become more sophisticated, the quality and comprehensiveness of training data will separate effective clinical tools from experimental prototypes.